Organizing Committee
Abdelaali Bariki
Pharma Expansion & Strategy Spain
Abdelaali Bariki
Pharma Expansion & Strategy SpainBiography
Abdelaali Bariki is an experienced pharmaceutical business development and strategic expansion professional based in Madrid, Spain, with extensive expertise across the MENA region, Asia, and Africa. He has been actively involved in international market development, healthcare partnerships, and strategic collaborations within the pharmaceutical and healthcare sectors. Through his leadership and industry experience, he continues to contribute to strengthening global healthcare networks and advancing innovation-driven healthcare initiatives worldwide.
Research Interest
His professional and research interests include pharmaceutical business development, global healthcare strategy, biotechnology innovation, precision medicine, healthcare commercialization, digital health, emerging pharmaceutical markets, and international collaborations focused on improving healthcare accessibility and advancing therapeutic innovation.
Dr . J. C. Tarafdar
Former ICAR Emeritus Scientist Indian
Dr . J. C. Tarafdar
Former ICAR Emeritus Scientist IndianBiography
Dr. J. C. Tarafdar is a distinguished scientist and academician with extensive contributions to agricultural science, soil microbiology, environmental sustainability, and arid zone research. He served as a UGC-Emeritus Professor, ICAR Emeritus Scientist, Principal Scientist, and National Fellow at the Central Arid Zone Research Institute, Jodhpur, Rajasthan. With decades of research and academic experience, Dr. Tarafdar has played a significant role in advancing sustainable agriculture, soil health management, and microbial biotechnology, particularly in arid and semi-arid ecosystems. He is widely recognized for his scientific achievements and has been honored with several prestigious fellowships, including FDAAD, FAvH, FNAAS, FISSS, FISSRS, and FSFE.
Research Interest
Dr. Tarafdar’s research interests include soil microbiology, Nanotechnology,sustainable agriculture, biofertilizers, environmental biotechnology, plant-microbe interactions, nutrient cycling, arid land ecosystem management, soil fertility improvement, organic farming, and climate-resilient agricultural practices. His work primarily focuses on developing eco-friendly and sustainable solutions for improving agricultural productivity and environmental conservation in arid and semi-arid regions.
Dr. Raja Prince-Eladnani
Biotech Innovator Switzerland
Dr. Raja Prince-Eladnani
Biotech Innovator SwitzerlandBiography
Dr. Raja Prince-Eladnani is a scientist, hemostasis expert, and biotech entrepreneur based in the Greater Bern Area, Switzerland. She currently serves as the CEO and Co-Founder of BLEEDnFIRE Therapeutics, a University of Bern spin-off focused on developing next-generation RNA therapies for inherited bleeding disorders, including hemophilia. In addition, she is associated with Inselspital Bern University Hospital and the University of Bern as a Senior Researcher and Scientist in the field of hematology and translational medicine. Dr. Prince-Eladnani specializes in pharmacology, pathophysiology, and hematology, with extensive research dedicated to innovative therapeutic approaches targeting rare blood and bleeding disorders. She completed her Master of Advanced Studies (MAS) in Translational Medicine and Biomedical Entrepreneurship at the University of Bern and has been actively contributing to the advancement of RNA-based therapeutics and precision medicine.
Research Interest
Dr. Raja Prince-Eladnani’s research interests include hematology, hemostasis, RNA therapeutics, inherited bleeding disorders, hemophilia research, translational medicine, precision medicine, pharmacology, pathophysiology, biotechnology innovation, rare blood disorders, protein S and Gas6 signaling pathways, regenerative therapeutics, and advanced therapeutic strategies for coagulation and bleeding-related diseases.
Dr. Prasun Chakraborty
Chief Executive Officer - Innovator Genevation United Kingdom
Dr. Prasun Chakraborty
Chief Executive Officer - Innovator Genevation United KingdomBiography
Prasun Chakraborty is an innovator, entrepreneur, and cancer vaccine pioneer with over 18 years of experience in IVT technology, oncology, and RNA biology. His scientific work has significantly advanced the understanding of transcription and splicing in cancer, particularly in pediatric oncology. As a scientist, speaker, and reviewer, Prasun has shared his expertise at leading international conferences, contributing to global conversations on cutting-edge cancer research.
Having worked across both academia and industry, Prasun is now focused on translating scientific breakthroughs into transformative therapies. He is leading the development of a groundbreaking cancer vaccine, combining his deep expertise in molecular biology with a commitment to bold, high-impact innovation.
Prasun’s key areas of expertise include IVT technology, RNA biology, oncology, transcription and splicing in cancer, biotech innovation, and fundraising. Through collaborations with investors, scientists, and visionary partners, he aims to push the boundaries of cancer treatment and bring life-changing therapies to patients worldwide.
Research Interest
Will be updated soon.
Prof .Panagiotis Sarigiannidis
Director of ITHACA Lab Greece
Prof .Panagiotis Sarigiannidis
Director of ITHACA Lab GreeceBiography
Prof. Panagiotis Sarigiannidis is the Director of the ITHACA Lab, Co-founder of MetaMind Innovations P.C., and Associate Professor in the Department of Electrical and Computer Engineering at the University of Western Macedonia, Greece. He received his B.Sc. and Ph.D. degrees in Computer Science from the Aristotle University of Thessaloniki, Greece. Prof. Sarigiannidis has established a strong international research profile with more than 330 scientific publications in leading journals, conferences, and book chapters. He has coordinated and participated in numerous European and international research projects, including Horizon 2020 and Horizon Europe initiatives focusing on smart grids, IoT ecosystems, cybersecurity, energy systems, and Beyond 5G technologies. His research contributions have earned several Best Paper Awards and the IEEE SMC TCHS Research and Innovation Award 2023. He is also an IEEE member and actively contributes to the scientific community through editorial and research activities in advanced communication and intelligent network systems.
Research Interest
Will be updated soon.
Dr. Sumeet Ambarkhane
Chief Medical Officer Germany
Dr. Sumeet Ambarkhane
Chief Medical Officer GermanyBiography
Dr. Sumeet Ambarkhane, MD, is a medical professional and biotechnology leader currently serving as the Chief Medical Officer at Pathios Therapeutics, Germany. He has extensive experience in clinical research, translational medicine, and the development of innovative therapeutic strategies. Dr. Ambarkhane has been actively involved in advancing precision medicine and next-generation therapeutic approaches with a strong focus on improving patient outcomes through scientific innovation and clinical excellence. His expertise spans clinical development, oncology, immunotherapy, and pharmaceutical research, contributing significantly to the advancement of modern healthcare and biotechnology initiatives.
Research Interest
Will be updated soon.
Dr. Lotti Dunne
Senior Research ScientistGermany
Dr. Lotti Dunne
Senior Research ScientistGermanyBiography
Lotti Dunne is a Research Scientist at Pantherna Therapeutics GmbH with expertise in mRNA delivery and next-generation therapeutic technologies. Her work focuses on advancing innovative RNA-based approaches for the development of precision therapeutics and targeted delivery systems. She is actively involved in research related to mRNA platform technologies, drug delivery strategies, and translational biomedical innovation. Through her scientific contributions, she supports the advancement of modern therapeutic solutions aimed at improving efficiency, safety, and clinical applications of RNA-based medicines.
Research Interest
mRNA delivery systems, RNA therapeutics, nanomedicine, drug delivery technologies, biotechnology, precision medicine, molecular therapeutics, translational medicine, lipid nanoparticles, targeted therapeutics, biomedical innovation, gene delivery systems, advanced therapeutics, pharmaceutical biotechnology, and next-generation healthcare technologies.
Mr. Jens Bergermann
SURSSwitzerland
Mr. Jens Bergermann
SURSSwitzerlandBiography
Jens Bergermann is a business and marketplace professional based in Switzerland, specializing in digital commerce, marketplace integration, and strategic business development. With extensive experience in connecting businesses through unified marketplace solutions, he focuses on helping organizations expand their reach, improve market visibility, and optimize commercial partnerships. His expertise spans e-commerce ecosystems, digital transformation, stakeholder engagement, and business growth strategies. Through his professional activities, he supports innovation and collaboration across Switzerland's digital marketplace landscape.
Research Interest
Digital marketplaces, e-commerce platforms, business development, digital transformation, marketplace integration, strategic partnerships, online retail ecosystems, platform economics, customer engagement, commercial innovation, stakeholder management, business networking, digital marketing, technology-driven business solutions, and sustainable business growth.
Dr. Erica Doutel
FEUP Portugal
Dr. Erica Doutel
FEUP PortugalBiography
Dr. Erica Doutel is a Scientific Researcher at the Faculty of Engineering of the University of Porto (FEUP), Portugal. Her research focuses on advancing engineering and technological solutions through interdisciplinary scientific investigation and innovation. She has contributed to academic research, collaborative projects, and the development of emerging technologies, with a strong commitment to scientific excellence, knowledge transfer, and international collaboration.
Research Interest
computational modeling, data-driven technologies, digital transformation, artificial intelligence applications.
